Provided by Tiger Fintech (Singapore) Pte. Ltd.

Argenx SE

645.14
+15.632.48%
Pre-market: 676.0130.87+4.79%08:17 EDT
Volume:319.80K
Turnover:205.48M
Market Cap:39.39B
PE:50.48
High:646.81
Open:637.10
Low:636.61
Close:629.51
Loading ...

Argenx announces Vyvgart, Vyvgart Hytrulo data

TIPRANKS
·
07 Mar

Biohaven Slumps, Again, As Bipolar Setback Outweighs A $4 Billion Opportunity

Blockhead
·
05 Mar

argenx Is Maintained at Neutral by Baird

Dow Jones
·
04 Mar

Argenx Se (ARGX) Receives a Buy from Morgan Stanley

TIPRANKS
·
03 Mar

Truist Financial Sticks to Their Buy Rating for Argenx Se (ARGX)

TIPRANKS
·
03 Mar

Rocket Pharmaceuticals Q4 Loss Narrower Than Estimates, Pipeline in Focus

Zacks
·
01 Mar

Argenx's Q4 Sales Backed by Vyvgart's Growth, Oppenheimer Says

MT Newswires Live
·
01 Mar

argenx Is Maintained at Outperform by Citizens Capital Markets

Dow Jones
·
28 Feb

Argenx Se (ARGX) Gets a Buy from Scotiabank

TIPRANKS
·
28 Feb

argenx Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
28 Feb

Exploring 3 High Growth Tech Stocks in Europe

Simply Wall St.
·
28 Feb

argenx SE reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
27 Feb

Argenx Q4 Swings to Earnings, Operating Income Increases

MT Newswires Live
·
27 Feb

argenx Q4 2024 GAAP EPS $11.79 Up From $(1.68) YoY, Sales $761.22M Beat $706.28M Estimate

Benzinga
·
27 Feb

argenx SE expected to post earnings of $1.32 a share - Earnings Preview

Reuters
·
25 Feb

argenx to Present at TD Cowen 45th Annual Healthcare Conference

GlobeNewswire
·
25 Feb

Argenx Vaults 3,659% With Profit Growth Seen In Triple Digits; Earnings Next As Stock Hits Highs

Blockhead
·
20 Feb

Here’s Why argenx SE (ARGX) Rose in Q4

Insider Monkey
·
19 Feb

Q4 2024 Halozyme Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
19 Feb